NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
09/14/2025
Back to search
Official data from USPTO
ACCEL RESEARCH SITES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACCEL RESEARCH SITES
ST13
US500000086955371Class
35, 42, 45
Filing
86955371
Registration
5435841
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
09/15/2025
Trademark type
Word
Nice classes
35, 42, 45
Filing date
03/28/2016
Registration date
04/03/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/19/2024
Last transaction
09/15/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
2015-06-00
First use in commerce
2015-06-00
Drawing code
4
Owner type
16
Owner location
Lake Mary, FL
Examiner
GARCIA, CLAUDIA
Current location
Historical data usage
Holders and representatives
Holders
Clinical Research Holdings, LLC
Clinical Research Holdings, LLC
Representatives
Mark A. Wright McLane Middleton, P.A.
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trials in all phases as it relates to pre-study document collection and reviewsite selectionvisits and auditssite complianceproject tracking and monitoring reportsnegotiation and administration of investigator grants and clinical trial budgets and contractsfinancial and management accountingdistributioncoordination and tracking of clinical trial products and materialsregulatory document processinglaboratory selection and coordination; Business consulting and management in the field of clinical trials in all phases as it relates to managing site and study-specific subject recruitment strategies and programs in the nature of contingency strategies and solutions to address specific project challenges; Business consulting and management in the field of clinical trials in all phases as it relates to managing the development of all study related documents and materials in the nature of study protocolscontractsbudgetsamendmentspaper and electronic case report formsinformed consent formssafety narrativespresentation posterstraining manuals; Business consulting and management in the field of clinical trials in all phases as it relates to managing all aspects of studydrug reconciliationinventory and distribution reports; Business management for all aspects of clinical trials in all phases as it relates to managing investigatorscoordinatorsmonitorstechniciansparticipants for compliance with clinical protocols and regulations; Business consulting and management in the field of clinical trials in all phases as it relates to management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials in all phases as it relates to ethical reviewssubmitting clinical trial protocols to institutional review boards and independent ethics committees on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical trials; Statistical analysis and reporting services for business purposes in the field of clinical trials; Business project management in the field of clinical trials in all phases as it relates to organizing and conducting business meetings of clinical trial investigators; Business managementmanaging randomization logisticsin the pharmaceutical and biotechnological field for business purposes; Development and implementation of personnel recruitment and retention programs for investigatorscoordinatorsmonitorstechnicians and participants for use in clinical trials; Business consulting and management in the field of clinical trials in all phases as it relates to the administration of protocols involving volunteer research patients and the recruiting of such volunteer research patients; Providing data management services in the medicalpharmaceutical and biotechnological field for business purposes
Class 42
Medical and scientific research consulting services for others in the field of designplanningimplementation of clinical trials in all phases; providing quality assurance services in the pharmaceutical and biotechnological industries
Class 45
Regulatory affairsreviewing standards and practices to assure compliance with clinical trial laws and regulations; Providing independent review of clinical trials involving human subjectsreviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research
Publications
History of USPTO decisions and trademark events.
52 publications found
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
09/14/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/08/2025
E15R
TEAS SECTION 15 RECEIVED
08/18/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/19/2024
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/19/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/19/2024
ES8R
TEAS SECTION 8 RECEIVED
04/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/29/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/29/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/29/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/29/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/29/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/03/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/03/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/16/2018
PUBO
PUBLISHED FOR OPPOSITION
01/16/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/27/2017
ALIE
ASSIGNED TO LIE
12/06/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/28/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
11/09/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/09/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
11/09/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/09/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/23/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/23/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/23/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/19/2017
GNRT
NON-FINAL ACTION E-MAILED
10/19/2017
CNRT
NON-FINAL ACTION WRITTEN
10/19/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/28/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/27/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/27/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/24/2017
GNRT
NON-FINAL ACTION E-MAILED
08/24/2017
CNRT
NON-FINAL ACTION WRITTEN
08/24/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
08/02/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/02/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
08/02/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/02/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/06/2017
GNRT
NON-FINAL ACTION E-MAILED
02/06/2017
CNRT
NON-FINAL ACTION WRITTEN
02/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/11/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/11/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/15/2016
GNRT
NON-FINAL ACTION E-MAILED
07/15/2016
CNRT
NON-FINAL ACTION WRITTEN
07/15/2016
DOCK
ASSIGNED TO EXAMINER
07/11/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/31/2016
NWAP
NEW APPLICATION ENTERED
03/31/2016
Continuous trademark protection
Get notified about every new filing that threatens ACCEL RESEARCH SITES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.